AstraZeneca said on Friday it will spend Ksh.323 billion on a research and development hub in Beijing, as the drugmaker ...
British pharmaceutical giant AstraZeneca signed a landmark agreement on Friday to invest $2.5 billion in Beijing over the next five years, signaling the multinational's confidence in the world's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback